Chain Drug Review - Omnitrope Pen 10 to hit market
September 29, 2008 -- PRINCETON, N.J. -- Sandoz has received Food and Drug Administration approval for its Omnitrope Pen 10 with liquid cartridge. Omnitrope, a somatropin,...
Business Wire - Tercica Initiates Phase II Clinical Trial with Next-Generation Growth Hormone Product for the Treatment of Short Stature
January 22, 2008 -- BRISBANE, Calif. -- Tercica, Inc. (NASDAQ: TRCA) today announced that the Company has begun dosing the first patient in a Phase II clinical study...
Biotech Business - ALTUS GETS POSITIVE RESULTS FROM ONCE-PER-WEEK GROWTH HORMONE.
August 1, 2006 -- Altus Pharmaceuticals Inc. (Nasdaq: ALTU), Cambridge, Mass. a biopharmaceutical company focused on the development and commercialization of oral...
Business Wire - Altus Pharmaceuticals Announces Positive Results from Phase II Study in Growth Hormone Deficient Patients with Once-Per-Week Growth Hormone
June 23, 2006 -- CAMBRIDGE, Mass. -- Altus Pharmaceuticals Inc. (Nasdaq: ALTU), a biopharmaceutical company focused on the development and commercialization of oral...
PR Newswire Europe - BioPartners Submits an Application for Approval of Valtropin (TM) a Recombinant Human Growth Hormone in Europe.
November 29, 2004 -- ZUG, Switzerland, November 29 /PRNewswire/ -- BioPartners, a global biopharmaceuticals company and one of the leaders in the emerging field of...
Pharmacy News - Growth hormone available.
December 8, 2005 -- Staff OMNITROPE (somatropin) -- a liquid formulation of recombinant human growth hormone, which mimics naturally occurring pituitary hormone --...
Business Wire - Altus Pharmaceuticals Presents Positive Data from Phase I Study of ALTU-238; First Patients Dosed in Phase II Trial in Adults with Growth Hormone Deficiency
September 28, 2005 -- CAMBRIDGE, Mass. -- Altus(R) Pharmaceuticals Inc., a company which is developing protein therapies to treat gastrointestinal and metabolic diseases,...
Business Wire - Altus Pharmaceuticals Announces Completion of Clinical Testing in the Phase I Study of ALTU-238 - a Long-Acting Crystalline Formulation of Human Growth Hormone
June 6, 2005 -- CAMBRIDGE, Mass. -- Plans to Initiate Phase II Multi-Center Trial in Adults with Growth Hormone Deficiency Altus(R) Pharmaceuticals Inc., a leader...
PR Newswire Europe - BioPartners GmbH Signs 10 Year License and Supply Agreement With The Medical House for Needle-Free Delivery System for Human Growth Hormone.
February 22, 2005 -- ZUG, Switzerland, February 22 /PRNewswire/ -- BioPartners, a global biopharmaceuticals company and one of the leaders in the emerging field of...
Business Wire - Teva and Savient Launch TEV-TROPIN for Pediatric Growth Hormone Deficiency
February 11, 2005 -- JERUSALEM -- Teva Pharmaceuticals Industries Ltd. (Nasdaq: TEVA) and Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) have announced the U.S. launch of...
